HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys

This article was originally published in The Tan Sheet

Executive Summary

Government regulation of dietary supplement safety is considered insufficient by nearly 60% of combined participants in several national surveys, researchers report in the March 26 Archives of Internal Medicine.

You may also be interested in...



Chronic Condition OTCs Safety Questioned By Consumers - CHPA Survey

U.S. consumers express ambivalence when it comes to treating chronic conditions with OTC medications, according to a survey released by the Consumer Healthcare Products Association March 21.

Garlic Trials Six-Month Minimum Duration Needed - AHRQ Report

Short-term garlic use may have antithrombotic benefits, although existing data are inconclusive, the Agency for Healthcare Research & Quality states in an evidence report released Oct. 3.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132297

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel